Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Other financing activities (2011 - 2022)

Grifols' (GIFLF) quarterly Other financing activities came in at -$2.8 million in Q4 2022, down 153.62% quarter-over-quarter from $5.3 million in Q1 2020.

Analysis

Grifols (GIFLF) Other financing activities (2011 - 2022) Analysis & Trends

Grifols (GIFLF) has reported Other financing activities for 11 consecutive years, with -$2.8 million the latest figure, recorded in Q4 2022.

  • For the quarter ending Q4 2022, Other financing activities changed N/A year-over-year to -$2.8 million; the trailing twelve-month figure through Dec 2022 stood at $25.3 million (changed N/A YoY), and the FY2025 full-year result was $41.8 million, down 24.77% from the prior year.
  • Other financing activities declined to -$2.8 million in Q4 2022 per GIFLF's latest filing, from $5.3 million in the prior quarter.
  • Across five years, Other financing activities topped out at $11.6 million in Q1 2019 and bottomed at -$2.8 million in Q4 2022.
  • Historically, Other financing activities has averaged $3.3 million across 4 years, with a median of $1.2 million in 2018.
  • The sharpest annual moves came in 2018 and 2019: Other financing activities tumbled 102.12% in 2018, then surged 1701.54% in 2019.
  • Over 4 years, Other financing activities stood at -$700817.4 in 2018, then jumped by 1701.54% to $11.2 million in 2019, then slumped by 52.75% to $5.3 million in 2020, then sank by 153.62% to -$2.8 million in 2022.
  • According to Business Quant data, Other financing activities over the past three periods registered -$2.8 million, $5.3 million, and $11.2 million for Q4 2022, Q1 2020, and Q4 2019 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -2.84 Mn
Mar 31, 2020 5.30 Mn
Dec 31, 2019 11.22 Mn
Mar 31, 2019 11.62 Mn
Dec 31, 2018 -700,817.41
Jun 30, 2018 -2.48 Mn
Mar 31, 2018 1.18 Mn
Dec 31, 2017 181.96 Mn
Jun 30, 2017 116.86 Mn
Mar 31, 2017 -103.56 Mn
Dec 31, 2016 6.06 Mn
Sep 30, 2016 -54.75 Mn
Dec 31, 2015 4.29 Mn
Sep 30, 2015 -2.97 Mn
Jun 30, 2015 30.03 Mn
Mar 31, 2015 -12.81 Mn
Dec 31, 2014 17.88 Mn
Sep 30, 2014 11.69 Mn
Jun 30, 2014 -3.53 Mn
Mar 31, 2014 3.77 Mn